Inbal Houri

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

"Overlap" Syndromes in Autoimmune Liver Disease: Definitions, Clinical Challenges and Future Directions.

"Overlap" Syndromes in Autoimmune Liver Disease: Definitions, Clinical Challenges and Future Directions.

Journal: Clinics in liver disease

Published: July 22, 2026

High biochemical remission rates in patients with primary biliary cholangitis treated with "triple" anticholestatic therapy.

High biochemical remission rates in patients with primary biliary cholangitis treated with "triple" anticholestatic therapy.

Journal: Hepatology communications

Published: March 28, 2025

Primary Biliary Cholangitis: Pathophysiology.

Primary Biliary Cholangitis: Pathophysiology.

Journal: Clinics in liver disease

Published: November 09, 2023

Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation.

Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation.

Journal: Journal of hepatology

Published: October 21, 2023

Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency Virus.

Barriers and Facilitators of Hepatitis C Care in Persons Coinfected with Human Immunodeficiency Virus.

Journal: International journal of environmental research and public health

Published: September 20, 2022

Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study.

Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study.

Journal: eLife

Published: May 03, 2022

Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients.

Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients.

Journal: Transplantation proceedings

Published: January 18, 2022

Real-World Management of Patients with Primary Biliary Cholangitis-A Retrospective Study from a Tertiary Medical Center in Israel.

Real-World Management of Patients with Primary Biliary Cholangitis-A Retrospective Study from a Tertiary Medical Center in Israel.

Journal: Journal of clinical medicine

Published: August 31, 2021

Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.

Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.

Journal: Clinical transplantation

Published: July 21, 2021

Repetitive amiodarone administration causes liver damage via adipose tissue ER stress-dependent lipolysis, leading to hepatotoxic free fatty acid accumulation.

Repetitive amiodarone administration causes liver damage via adipose tissue ER stress-dependent lipolysis, leading to hepatotoxic free fatty acid accumulation.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: July 14, 2021

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.

Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients.

Journal: Journal of hepatology

Published: April 03, 2021

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: March 21, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026